Clinical Development Pharmacokinetics Vaccine 
PPD
MAY 11, 2023
The global COVID-19 pandemic increased awareness of the importance of vaccine development — both for drug developers and the public. The speed at which COVID-19 vaccines were developed was remarkable, but like most newly developed vaccines, there was variation among who could receive the shots and when.
The Pharma Data
JULY 21, 2021
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. About Merck.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
DrugBank
JUNE 18, 2025
Regulatory agencies require pharmaceutical companies to submit preclinical and clinical trial data covering toxicology, pharmacokinetics, pharmacodynamics, and long-term safety monitoring. These submissions contain comprehensive data on clinical efficacy, pharmacokinetics, pharmacodynamics, and risk-benefit assessments.
The Pharma Data
DECEMBER 13, 2020
Food and Drug Administration (FDA) ’s focus appears to be on Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech and Moderna COVID-19 vaccines, as the year wraps up there are still some PDUFA dates on the agency’s calendar. Zai Lab is leading clinical development in its territory. “We Although much of the U.S.
Agency IQ
SEPTEMBER 22, 2023
The guidance concludes with a brief section on “process considerations” that strongly emphasizes the importance of rationalizing the chosen approach to establishing efficacy with high specificity early in the clinical development process. When should this occur? at the end-of-phase 2 meeting).
The Pharma Data
JANUARY 3, 2021
The pharmacokinetics of nasally administered Foralumab will also be evaluated. Patient reported outcome to assess clinical responses related to COVID-19 symptoms, as per the FDA guidelines, will also be collected. A further announcement will be made in due course.
PPD
JUNE 20, 2023
Likewise, and particularly since partnering with Moderna on the development of its COVID-19 vaccine, we know that novel therapeutic platforms will continue to hold strong potential for priority therapeutic areas. Does your CRO leverage data-backed intelligence to accelerate your clinical development strategy?
Expert insights. Personalized for you.
52 
Let's personalize your content